Literature DB >> 10403730

Synergistic effects of interferon gamma and tumour necrosis factor alpha on T84 cell function.

S M Fish1, R Proujansky, W W Reenstra.   

Abstract

BACKGROUND: Inflammatory bowel disease (IBD) is characterised by chronic intestinal inflammation and increased epithelial permeability. Both tumour necrosis factor alpha (TNF-alpha) and interferon gamma (IFN-gamma) have been implicated in IBD. AIMS: To understand better the effects of these cytokines on epithelial cell function.
METHODS: T84 cells were cultured with IFN-gamma and TNF-alpha and changes in transepithelial resistance (TER), fluorescein isothiocyanate (FITC) dextran flux, short circuit current (I(sc)), cystic fibrosis transmembrane conductance regulator (CFTR) protein levels, cell morphology, TNF receptor gene expression, and apoptosis were assayed.
RESULTS: Relative to controls, significant changes (p<0.05) occurred in cells incubated with IFN-gamma for two days: TER was decreased to 20 (6.2)%, FITC-dextran flux was increased by 109 (19)-fold, cAMP and Ca dependent I(sc) were decreased to 51 (6.4)% and 24 (2.2)%, respectively, and CFTR levels were decreased to 47 (11)%. Cell morphology was altered but cell death was not induced. TNF receptor mRNA levels were increased. When added with IFN-gamma, TNF-alpha accelerated IFN-gamma dependent changes. Relative to controls, significant changes occurred after one day of culture with IFN-gamma plus TNF-alpha: TER was decreased to 27 (3.5)%, FITC-dextran flux was increased by 185 (45)-fold, and cAMP and Ca dependent I(sc) were decreased to 66 (12)% and 35 (6.8)%, respectively. TNF-alpha also enhanced IFN-gamma dependent changes in cell morphology but did not induce cell death.
CONCLUSION: IFN-gamma alters T84 cell epithelial properties and TNF-alpha can enhance these effects, perhaps due to IFN-gamma dependent increases in TNF receptor gene expression. Overall, these studies suggest that in IBD, TNF-alpha may have synergistic effects on IFN-gamma mediated alterations of epithelial cell function.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10403730      PMCID: PMC1727614          DOI: 10.1136/gut.45.2.191

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  35 in total

1.  Randomised controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohn's disease.

Authors:  W A Stack; S D Mann; A J Roy; P Heath; M Sopwith; J Freeman; G Holmes; R Long; A Forbes; M A Kamm
Journal:  Lancet       Date:  1997-02-22       Impact factor: 79.321

2.  Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine.

Authors:  T T MacDonald; P Hutchings; M Y Choy; S Murch; A Cooke
Journal:  Clin Exp Immunol       Date:  1990-08       Impact factor: 4.330

3.  Gene induction by gamma-irradiation leads to DNA fragmentation in lymphocytes.

Authors:  K S Sellins; J J Cohen
Journal:  J Immunol       Date:  1987-11-15       Impact factor: 5.422

4.  A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion.

Authors:  H C Jung; L Eckmann; S K Yang; A Panja; J Fierer; E Morzycka-Wroblewska; M F Kagnoff
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

5.  IL-4 directly modulates function of a model human intestinal epithelium.

Authors:  S P Colgan; M B Resnick; C A Parkos; C Delp-Archer; D McGuirk; A E Bacarra; P F Weller; J L Madara
Journal:  J Immunol       Date:  1994-09-01       Impact factor: 5.422

6.  A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor.

Authors:  T Kohno; M T Brewer; S L Baker; P E Schwartz; M W King; K K Hale; C H Squires; R C Thompson; J L Vannice
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

7.  Expression and characterization of the cystic fibrosis transmembrane conductance regulator.

Authors:  R J Gregory; S H Cheng; D P Rich; J Marshall; S Paul; K Hehir; L Ostedgaard; K W Klinger; M J Welsh; A E Smith
Journal:  Nature       Date:  1990-09-27       Impact factor: 49.962

8.  Renal allograft rejection: expression and function of VCAM-1 on tubular epithelial cells.

Authors:  Y Lin; J A Kirby; D A Browell; A R Morley; B K Shenton; G Proud; R M Taylor
Journal:  Clin Exp Immunol       Date:  1993-04       Impact factor: 4.330

9.  Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR).

Authors:  M Niessner; B A Volk
Journal:  Clin Exp Immunol       Date:  1995-09       Impact factor: 4.330

10.  Expression of mRNA for 55-kDa and 75-kDa tumor necrosis factor (TNF) receptors in mouse cerebrovascular endothelium: effects of interleukin-1 beta, interferon-gamma and TNF-alpha on cultured cells.

Authors:  B F Bebo; D S Linthicum
Journal:  J Neuroimmunol       Date:  1995-11       Impact factor: 3.478

View more
  42 in total

1.  A coculture model mimicking the intestinal mucosa reveals a regulatory role for myofibroblasts in immune-mediated barrier disruption.

Authors:  L E M Willemsen; C C H M Schreurs; H Kroes; E J Spillenaar Bilgen; S J H Van Deventer; E A F Van Tol
Journal:  Dig Dis Sci       Date:  2002-10       Impact factor: 3.199

2.  Differentiation restricted endocytosis of cell penetrating peptides in MDCK cells corresponds with activities of Rho-GTPases.

Authors:  Christina Foerg; Urs Ziegler; Jimena Fernandez-Carneado; Ernest Giralt; Hans P Merkle
Journal:  Pharm Res       Date:  2007-03-03       Impact factor: 4.200

3.  Tumor necrosis factor-alpha and interferon-gamma increase PepT1 expression and activity in the human colon carcinoma cell line Caco-2/bbe and in mouse intestine.

Authors:  Stephan R Vavricka; Mark W Musch; Mikihiro Fujiya; Keri Kles; Laura Chang; Jyrki J Eloranta; Gerd A Kullak-Ublick; Ken Drabik; Didier Merlin; Eugene B Chang
Journal:  Pflugers Arch       Date:  2005-11-19       Impact factor: 3.657

Review 4.  Tight junctions in salivary epithelium.

Authors:  Olga J Baker
Journal:  J Biomed Biotechnol       Date:  2010-02-18

5.  Signaling of short- and long-term regulation of intestinal epithelial type 1 Na+/H+ exchanger by interferon-gamma.

Authors:  Fernando Magro; Sónia Fraga; Patrício Soares-da-Silva
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

6.  Impaired rejection and mucosal injury of small intestinal allografts lacking the interferon-gamma receptor.

Authors:  Andrew M Veitch; Lisa M Higgins; Mona Bajaj-Elliot; Michael J G Farthing; Thomas T MacDonald
Journal:  Int J Exp Pathol       Date:  2003-06       Impact factor: 1.925

7.  Guanylate-binding protein-1 is expressed at tight junctions of intestinal epithelial cells in response to interferon-gamma and regulates barrier function through effects on apoptosis.

Authors:  M Schnoor; A Betanzos; D A Weber; C A Parkos
Journal:  Mucosal Immunol       Date:  2008-09-17       Impact factor: 7.313

8.  Enterococcus faecalis Gelatinase Mediates Intestinal Permeability via Protease-Activated Receptor 2.

Authors:  Nitsan Maharshak; Eun Young Huh; Chorlada Paiboonrungruang; Michael Shanahan; Lance Thurlow; Jeremy Herzog; Zorka Djukic; Roy Orlando; Rafal Pawlinski; Melissa Ellermann; Luke Borst; Siten Patel; Iris Dotan; Ryan B Sartor; Ian M Carroll
Journal:  Infect Immun       Date:  2015-04-27       Impact factor: 3.441

Review 9.  Cytokine regulation of tight junctions.

Authors:  Christopher T Capaldo; Asma Nusrat
Journal:  Biochim Biophys Acta       Date:  2008-10-08

10.  Sieving characteristics of cytokine- and peroxide-induced epithelial barrier leak: Inhibition by berberine.

Authors:  Katherine M DiGuilio; Christina M Mercogliano; Jillian Born; Brendan Ferraro; Julie To; Brittany Mixson; Allison Smith; Mary Carmen Valenzano; James M Mullin
Journal:  World J Gastrointest Pathophysiol       Date:  2016-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.